🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 2 Study to investigate the safety, tolerability, and anti-t...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2023-08-03
Trial ID
NCT05963347
Treatments Being Tested
The aim of this work is to assess the antitumor effect of Pentoxiphylline i...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11-01
Trial ID
NCT06115174
Treatments Being Tested
RATIONALE: Vandetanib may stop the growth of cancer cells by blocking some ...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2008-03
Trial ID
NCT00734890
Treatments Being Tested
Outcomes for adult patients with Severe Aplastic Anemia (SAA) aged more tha...
Status
Recruiting
Location
Saint Louis hospital
Start Date
2025-01-24
Trial ID
NCT06646497
Treatments Being Tested
This is a randomized, open-label, prospective, multicenter phase III superi...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center,
Start Date
2026-08-11
Trial ID
NCT07678229
RATIONALE: Pemetrexed may stop the growth of cancer cells by blocking some ...
Status
Completed
Location
Vanderbilt-Ingram Cancer Center
Start Date
2004-05
Trial ID
NCT00470405
Treatments Being Tested
The primary objective of this study is to evaluate the tolerability and saf...
Status
Completed
Location
Eisai Trial Site 5
Start Date
2017-11-28
Trial ID
NCT03386942
Treatments Being Tested
This is an early phase trial designed to evaluate the safety, tolerability,...
Status
Recruiting
Location
START Midwest
Start Date
2025-12-12
Trial ID
NCT07293754
Treatments Being Tested
Phase I trial to study the effectiveness of BMS-247550 in treating patients...
Status
Completed
Location
Cancer Therapy and Research Center
Start Date
2000-11
Trial ID
NCT00006221
Treatments Being Tested
This was an open-label, nonrandomized, Phase 1/2 study designed to determin...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2017-05-02
Trial ID
NCT03085914